ABSTRACT: The purpose of the review was to synthesize the current literature regarding the effect of miRNA on biological processes known to be involved in tendon and tenocyte development and homeostasis. Using multiple databases, a systematic review was performed with a customized search term crafted to identify any study examining micro-RNA in relation to tendon and/or tenocytes. Results were classified based on the following categories: Gene expression, tenocyte development and differentiation, tendon tissue repair, and tenocyte senescence. A total of 3,112 potentially relevant studies were reviewed, and after exclusion criteria was applied, 15 investigations were included in the final analysis. There were 14 specific miRNA included in this review, with 11 studies reporting on tendon-related gene expression, five reporting on tendon development and/or tenocyte differentiation, six reporting on tendon tissue repair, and five reporting on tenocyte senescence. The miR-29 family was the most commonly reported micro-RNA in the investigation. We also report on a number of micro-RNA which are associated with both positive and negative effects on tendon homeostasis. ß
Tendinopathy is a common musculoskeletal condition which can affect many body areas. Up to 30% of all office visit-related musculoskeletal complaints are due to a diagnosis of tendinopathy. 1 Furthermore, 30% of patients with tendinopathy are not able return to prior levels of physical activity. 2 Despite extensive research, a single molecular process leading to the development of tendinopathy and tendon-related pain has not been elucidated.
Normal tendon is mainly composed collagen, which accounts for over 90% of its dry mass. The collagen portion is made up of 98% Type I collagen (Col1). 3 In healthy tendons, Col1 is arranged in a regular linear pattern with tenocytes interspersed among the collagen. In diseased tendons, however, Type III collagen (Col3) is increased as compared to non-diseased tendons. Tenocytes also undergo phenotypic changes, leading to collagen disorganization, and degeneration and a subsequent decrement in biomechanical strength. 4 In addition, there is a significant increase in the presence of inflammatory mediators. 5, 6 MicroRNAs (miRNAs) have been shown to have regulatory control of over one-third of human protein coding genes, 7 including those regulating collagen 8 and the production of inflammatory mediators. 9 These molecules are small, non-coding RNAs involved in mRNA regulation at a post-transcriptional level, often acting as inhibitors to gene expression. MiRNAs bind to the 3 0 -UTR of target mRNA resulting in, most cases, inhibition of translation or targeted degradation of the mRNA itself. 10 Non canonical binding, such as to 5 0 -UTR and as well as within the coding sequence of the mRNA transcript, has also been reported.
11
There has been interest regarding the effect of miRNA on tenogenic-related gene expression and tenocyte differentiation. Other investigations have shown a variety of effects on tendon-derived stem cells (TDSCs) 12 as well as modification of collagen expression. 13 This suggests that miRNA may play a role in the development of tendinopathy. The literature examining miRNA and its effect on tenogenic-related gene expression and tendinopathy development remains disparate. Through a systematic review, we aim to synthesize the current literature regarding the effect of miRNA on biological processes known to be involved in tendon development and homeostasis.
METHODS
A systematic review of the available literature was performed with the use of PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analyses) guidelines and checklist (Fig. 1 ).
14 The search was completed on November 12, 2017, using an explicit search algorithm 15 within the following databases: PubMed/MEDLINE and Scopus. The search term was crafted to identify any study examining micro-RNA in relation to tendon and/or tenocytes. Levels I, II, III, and IV evidence (according to the Oxford Centre for Evidence-Based Medicine used by the American version of the Journal of Bone and Joint Surgery 16 ) English-language studies were eligible for inclusion in this review. Both print journal and electronically published articles were eligible for inclusion. Medical conference abstracts were not eligible for inclusion. All references within included studies were cross-referenced and assessed for potential inclusion if missed by the initial search.
The primary outcome measure of interest determining inclusion in this review was miRNA and related alternations in tenocytes and tenogenic-related gene expression. Results were classified based on the following categories: Gene expression, tenocyte development and differentiation, tendon tissue repair, and tenocyte senescence ( equine). Exclusion criteria were: Non-English-language studies, non-miRNA-related studies, non-tendon/tenocyte-related studies, small nuclear (snRNA), or small cytoplasmic (scRNA)-related studies, letters to the editor, conference abstract/ proceedings, studies which did not specifcy a particular micro-RNA, and other systematic reviews or meta-analyses.
RESULTS
A total of 3,112 potentially relevant studies were reviewed and 3,032 were initially excluded for being non-miRNArelated, leaving 180 studies available for review (Fig. 1) . The 180 studies available for review was reduced to 33 studies, on the basis of 147 studies containing nontendon/tenocytes related topics. Then, of the 33 studies, 18 studies were eliminated based on not including miRNA-specific names, leaving 15 available for review and included in the current investigation ( Figure 1 ).
There were 14 specific miRNA included in this review, with 12 studies being classified as reporting on tendon-related gene expression, five reporting on tendon development and/or tenocyte differentiation, seven reporting on tendon tissue repair, and five reporting on tenocyte senescence. Approximately 50% (7/16) of the included studies were conducted using human tendon samples, while chicken, rat, equine, and mouse comprised the other model organisms from which tendon tissue/tenocytes were derived (Table 1) .
Micro-RNA had a variable effect on gene expression (Table 2) , with modulation by TGF-B1 and chitosan 17 and mediated by pathways such as ROCK1 for miRNA-135a, 18 which were shown to regulate miRNA135a overall expression. Micro-RNA also had a variable effect on tendon development and tenocyte differentiation (Table 3) , acting in some reports to suppress collagen formation, 19 and also targeting specific proteins (p16 20 and p27kip1 21 ) to modulate tenocyte differentiation. Regarding tissue repair (Table 4) , increased expression of TGF-B1 and decreased expression of IL-33 led to tendon repair by down-regulating miR29a. 22 Similar to tendon repair, increased expression of miRNA resulted in reduced senescence in TSPCs (Table 5 ) through pro-apoptotic mechanisms and downregulation of ROCK1 18 and Pin1. 23 Of all the micro-RNA investigated, miRNA-29 was reported the most frequently. Micro-RNA-29b demonstrated a negative effect on expression of TGF-B1, in which downregulation of miRNA-29b resulted in improved function and repair of tendons. This study reported on the negative effect of miRNA-29b through TGF-B1/Smad3, 17 demonstrating its ability to modulate other molecular pathways in the tissue repair process. Another study reported on the down-regulation of miRNA-29a by IL-33, leading to increased expression of Col3 and subsequent biomechanical inferiority. 22 
DISCUSSION
This systematic review examined the effect of micro-RNA on tendon development and homeostasis. Such an analysis has led to findings and a summary of variable trends across organisms and type of tendon in terms of the effect of micro-RNA on tendon-related gene expression, tenocyte development, tendon repair, and tenocyte senescence.
Within this review, distinct approaches were utilized to investigate the role of miRNAs on tenocytes and potentially, the role of miRNAs on tendinopathy. One approach focused on a specific collagen transcripts and then analyzed the expressions of the gene and its target miRNA between control group and tendinopathy group. 24 Another approach identified differentially expressed miRNAs by comparing control group and tendinopathy group. 25 These approaches provided a novel insight into the mechanobiology of tendons and the role of tendon adaptability to growth stimuli. In addition to direct approaches, other studies demonstrated miRNA's modulation on TSPC senescence, and the influence of oxidative stress on tenocyte-induced apoptosis through modulation of miRNA expression. 26 The molecular changes leading to tendinopathy are still being examined in order to identify causative factors in the disease process. Mechanistically, one theory posits that hypoxia promotes the expression of pro-inflammatory cytokines and key apoptotic mediators, 27 ,28 a critical step in the development of tendinopathy. Another investigation, however, found that hypoxic-conditioned culture medium could enhance tendon-like properties of aged tendon stem cells. 29 With respect to the relationship of micro-RNA and hypoxia, miRNA29a was found to alter the hypoxia response of tenocytes through the IL-33 signaling pathway. 22 Other microRNAs (À26, À107, and À210) were found to decrease pro-apoptotic signaling in a hypoxia environment, demonstrating a negative modulation of the proposed inflammatory response. 30 Micro-RNA-29 was the most commonly reported in this investigation. Micro-RNA 29a inhibited expression of IL-33, a signal of inflammation and a detrimental molecule when considering tendon homeostasis and repair. 22 Down-regulation of micro-RNA 29a also led to increased Col3 expression 22 while miRNA-29b led to decreased Co1 and Col3 expression. 8 In tendinopathy, induction of miRNA-206 with growth factors (TGF-B1) aids in treating injured tendons while still allowing for tendon gliding within the sheath. 21 Micro-RNA-29b downregulated TGF-B1/Smad3, which improved tendon healing 17 and accelerated tenogenic differentiation. 31 Micro-RNA-29b's downregulation of TGF-B1 also led to an increased gliding excursion of the repaired tendon. Finally, miR-29b was shown to be a negative regulator of TGF-B1 and Col1 expression. Interestingly, while the binding site of miR-29b on Col1 is in the 3 0 -UTR, the binding site for miR-29b on TGF-B1 is in the coding region, 31 highlighting the possibility of non-canonical binding interactions between micro-RNAs and their targets.
Mechanistically, Millar et al. 22 have demonstrated that IL-33, acting through its cognate receptor ST2 and signaling via the canonical IL1R signaling cas-cade, likely play a significant role in tendon pathology. Their data show that the IL-33/ST2 system functions in early tendon disease by triggering the production of inflammatory mediators and switching collagen production away from Col1 and towards Col3, which is known to be present in increased quantities in tendinopathic tissue. Most pertinent to this investigation was their finding that miR-29a acts to regulate tenocyte biology by integrating IL-33 expression, soluble ST2 receptor availability, and Col3 expression. They demonstrate that IL-33, acting through NF-kB, downregulates miR-29a, suggesting that addition of miR-29a after tendon injury may improve tendon healing and recovery.This hypothesis was tested in a randomized control trial in which equines received miR29a replacement therapy following superficial digital flexor tendon injury. 32 
Watts et al. reported decreased
Col3 expression as well as decreased lesion size and improved histology scores for animals receiving treatment, 32 suggesting that miR-29a improves early tendon healing and modulates early pathophysiologic events that facilitate tendon tissue remodeling after injury.
Other prominent micro-RNA featured in this review include miRNA-217, which was shown to target EGR-1 20 and acted to increase tenogenic differentiation in young TSPCs. 20 It also demonstrated decreased Col1 20 which is similar to the actions of miRNA-29b in collagen fiber inhibition. Micro-RNA-140 also demonstrated multiple functions, with upregulation of TGF-B1 while mediating the reduction in mechanical loading. 21 It also served to downregulate Pin1 expression, which acts to regulate TSPC aging as well as senescence in TSPC. Lastly, miRNA-135a mediates ROCK1, a Rho-associated serine/threonine kinase family member which is downregulated in young TSPCs 18 and upregulated in aged and senescent TSPCs. 33 ROCK1 is important in a number of cellular functions, including organization and expression of actin filaments as well as a regulator of the cell cycle. 34 Overexpression of miR-135a in young TSPCs suppresses senescence, promotes proliferation, and induces migration and tenogenic differentiation, whereas suppression of miR-135a in aged TSPCs has the opposite effects. 18 Taken together, these data suggest a multifactorial role of the effect of miRNA on tenocyte and TSPC development, senescence, and gene expression. Because of this diversity, it is not feasible to characterize all micro-RNA as having a positive or negative effect on tenocytes, TSPC, or even the development of tendinopathy. As with most biological processes, an individualized approach is required to discern the effect of each miRNA on tenocyte pathways, talking into account that environmental factors (such as hypoxia) may further alter biological responses and processes. This diversity, however, raises the possibility of utilizing micro-RNA to target specific pathways leading to tendon-related disorders and therefore provide potential therapeutic benefit to those with tendinopathy-related pain.
CONCLUSIONS
The miR-29 family was the most commonly reported micro-RNA in the investigation. We report on a number of other micro-RNA which are associated with both positive and negative effects on tendon and tenocyte homeostasis and development.
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